Ronald Zolty is a specialist in adult cardiology, interventional cardiology, and advanced heart failure and transplant cardiology. He attended medical school at the University of Geneva Faculty of Medicine. His areas of expertise consist of heart failure, left ventricular assist device (LVAD), and pulmonary hypertension. Dr. Zolty is in-network for Medicare insurance. He is affiliated with Nebraska Medicine.
- 1980-1983: BS, Mathematics & Physics, Academy of Haute-Savoie, Fr/Swiss Academy, Bern, Switzerland.
- 1983-1990: MD, Faculty of Medicine, University of Geneva, Geneva Switzerland.
- 2001-2007: PhD, PhD in Clinical Science, University of Colorado.
- Zolty R, Carroll JD. Acute Myocardial Infarction after Blunt Chest Trauma. Multimedia Review of Invasive Cardiology. 1997
- Zolty, R; Lowes BD. Diagnosis and Treatment of Heart Failure. Primary Care Case Reviews. 1999; p. 1-8
- Zolty, R. BNP, a New Tool for Managing Congestive Heart Failure. Primary Care Case Reviews. 2003; p. 21-28
- Shakar SF, Lowes BD, Lindenfeld J, Zolty R, Simon M, Robertson AD, Bristow MR, Wolfel EE. Peak oxygen consumption and outcome in heart failure patients chronically treated with beta-blockers. J Card Fail. 2004 Feb;10(1):15-20. doi: 10.1016/s1071-9164(03)00593-1. PMID: 14966770
- Lindenfeld J, Miller GG, Shakar SF, Zolty R, Lowes BD, Wolfel EE, Mestroni L, Page RL, Kobashigawa J. Drug therapy in the heart transplant recipient: part I: cardiac rejection and immunosuppressive drugs. Circulation. 2004 Dec 14;110(24):3734-40. doi: 10.1161/01.CIR.0000149745.83186.89. PMID: 15596559
- Lindenfeld J, Miller GG, Shakar SF, Zolty R, Lowes BD, Wolfel EE, Mestroni L, Page RL, Kobashigawa J. Drug therapy in the heart transplant recipient: part II: immunosuppressive drugs. Circulation. 2004 Dec 21;110(25):3858-65. doi: 10.1161/01.CIR.0000150332.42276.69. PMID: 15611389
- Lindenfeld J; Miller GG; Zolty, R; Shakar SF; Levi M; Lowes BD; Wolfel EE; Miller GG. Drug therapy in the heart transplant recipient: Part III: Common medical problems. Drug therapy in the heart transplant recipient: Part III: common medical problems. Circulation. 2005 Jan 4;111(1):113-7. Doi: 10.1161/01.CIR.0000151609.60618.3C. PMID: 15630040
- Lindenfeld JA, Simon SF, Zamora MR, Cool CD, Wolfel EE, Lowes BD, Ireland N, Keller K, Frisk R, Stepien L, Cleveland JC, Zolty R. BOOP is common in cardiac transplant recipients switched from a calcineurin inhibitor to sirolimus. Am J Transplant. 2005 Jun;5(6):1392-6. doi: 10.1111/j.1600-6143.2005.00849.x. PMID: 15888046
- Juang P, Page RL, Zolty R. A successful rapid desensitization protocol in a loop diuretic allergic patient. J Card Fail. 2005 Aug;11(6):481. doi: 10.1016/j.cardfail.2005.03.005. PMID: 16105640
- Juang P, Page RL, Zolty R. Probable loop diuretic-induced pancreatitis in a sulfonamide-allergic patient. Ann Pharmacother. 2006 Jan;40(1):128-34. doi: 10.1345/aph.1G314. Epub 2005 Dec 13. PMID: 16352777
- Lowes BD, Zolty R, Minobe WA, Robertson AD, Leach S, Hunter L, Bristow MR. Serial gene expression profiling in the intact human heart. J Heart Lung Transplant. 2006 May;25(5):579-88. doi: 10.1016/j.healun.2006.01.006. Epub 2006 Apr 11. PMID: 16678038
- Tate CW, Robertson AD, Zolty R, Shakar SF, Lindenfeld J, Wolfel EE, Bristow MR, Lowes BD. Quality of life and prognosis in heart failure: results of the Beta-Blocker Evaluation of Survival Trial (BEST). J Card Fail. 2007 Nov;13(9):732-7. doi: 10.1016/j.cardfail.2007.07.001. PMID: 17996821
- Lowes BD, Zolty R, Shakar SF, Brieke A, Gray N, Reed M, Calalb M, Minobe W, Lindenfeld J, Wolfel EE, Geraci M, Bristow MR, Cleveland J. Assist devices fail to reverse patterns of fetal gene expression despite beta-blockers. J Heart Lung Transplant. 2007 Nov;26(11):1170-6. doi: 10.1016/j.healun.2007.08.003.PMID: 18022084
- Vittorio TJ, Zolty R, Kasper ME, Khandwalla RM, Hirsh DS, Tseng CH, Jorde UP, Ahuja K. Differential effects of carvedilol and metoprolol succinate on plasma norepinephrine release and peak exercise heart rate in subjects with chronic heart failure. J Cardiovasc Pharmacol Ther. 2008 Mar;13(1):51-7. doi: 10.1177/1074248407312629. PMID: 18287590
- Zolty R, Bauer C, Allen P, Garrity M, Vittorio TJ. Atrial natriuretic peptide stability. Clin Biochem. 2008 Oct;41(14-15):1255-8. doi: 10.1016/j.clinbiochem.2008.05.008. Epub 2008 May 27. PMID: 18539145
- Zolty R, Hynes PJ, Vittorio TJ. Severe left ventricular systolic dysfunction may reverse with renal transplantation: uremic cardiomyopathy and cardiorenal syndrome. Am J Transplant. 2008 Nov;8(11):2219-24. doi: 10.1111/j.1600-6143.2008.02407.x. Epub 2008 Sep 19. PMID: 18808406
- Vittorio TJ, Zolty R, Garg PK, Sarswat N, Tseng CH, Jorde UP, Colombo PC. Interdependence of cardiac and endothelial function in patients with symptomatic chronic heart failure of nonischemic etiology. Echocardiography. 2009 Sep;26(8):916-21. doi: 10.1111/j.1540-8175.2009.00907.x. Epub 2009 May 26. PMID: 19486111
- Weatherley BD, Cotter G, Dittrich HC, DeLucca P, Mansoor GA, Bloomfield DM, Ponikowski P, O'Connor CM, Metra M, Massie BM, PROTECT Steering Committee, Investigators, and Coordinators. Design and rationale of the PROTECT study: a placebo-controlled randomized study of the selective A1 adenosine receptor antagonist rolofylline for patients hospitalized with acute decompensated heart failure and volume overload to assess treatment effect on congestion and renal function. J Card Fail. 2010 Jan;16(1):25-35. doi: 10.1016/j.cardfail.2009.10.025. Epub 2009 Dec 11.PMID: 20123315
- Chandra R, Zolty R, Palma E. A left hemiblock improves cardiac resynchronization therapy outcomes in patients with a right bundle branch block. Clin Cardiol. 2010 Feb;33(2):89-93. doi: 10.1002/clc.20708. PMID: 20186989
- Vittorio TJ, Lanier G, Zolty R, Sarswat N, Tseng CH, Colombo PC, Jorde UP. Association between endothelial function and chronotropic incompetence in subjects with chronic heart failure receiving optimal medical therapy. Echocardiography. 2010 Mar;27(3):294-9. doi: 10.1111/j.1540-8175.2009.01011.x. Epub 2010 Jan 11.PMID: 20070352
- Massie BM, O'Connor CM, Metra M, Ponikowski P, Teerlink JR, Cotter G, Weatherley BD, Cleland JG, Givertz MM, Voors A, DeLucca P, Mansoor GA, Salerno CM, Bloomfield DM, Dittrich HC, PROTECT Investigators and Committees. Rolofylline, an adenosine A1-receptor antagonist, in acute heart failure. N Engl J Med. 2010 Oct 7;363(15):1419-28. doi: 10.1056/NEJMoa0912613. PMID: 20925544
- Huffman C, Wagman G, Fudim M, Zolty R, Vittorio T. Reversible cardiomyopathies--a review. Transplant Proc. 2010 Nov;42(9):3673-8. doi: 10.1016/j.transproceed.2010.08.034. PMID: 21094837
- Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Piccini JP, Becker RC, Nessel CC, Paolini JF, Berkowitz SD, Fox KA, Califf RM, ROCKET AF Investigators. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011 Sep 8;365(10):883-91. doi: 10.1056/NEJMoa1009638. Epub 2011 Aug 10. PMID: 21830957
- Salamon JN, Mazurek J, Zolty R. Postmenopausal women with constipation and cardiovascular disease. Am J Med. 2012 Feb;125(2):e5; author reply e7-8. doi: 10.1016/j.amjmed.2011.08.023. PMID: 22269632
- Kelesidis I, Mazurek J, Khullar P, Saeed W, Vittorio T, Zolty R. The effect of nesiritide on renal function and other clinical parameters in patients with decompensated heart failure and preserved ejection fraction. Congest Heart Fail. 2012 May-Jun;18(3):158-64. doi: 10.1111/j.1751-7133.2011.00272.x. Epub 2011 Nov 27.PMID: 22497779
- Hankey GJ, Patel MR, Stevens SR, Becker RC, Breithardt G, Carolei A, Diener HC, Donnan GA, Halperin JL, Mahaffey KW, Mas JL, Massaro A, Norrving B, Nessel CC, Paolini JF, Roine RO, Singer DE, Wong L, Califf RM, Fox KA, Hacke W, ROCKET AF Steering Committee Investigators. Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischemic attack: a subgroup analysis of ROCKET AF. Lancet Neurol. 2012 Apr;11(4):315-22. doi: 10.1016/S1474-4422(12)70042-X. Epub 2012 Mar 7. PMID: 22402056
- Ghali JK, Orlandi C, Abraham WT, CK-LX2401 Study Investigators. The efficacy and safety of lixivaptan in outpatients with heart failure and volume overload: results of a multicentre, randomized, double-blind, placebo-controlled, parallel-group study. Eur J Heart Fail. 2012 Jun;14(6):642-51. doi: 10.1093/eurjhf/hfs051. Epub 2012 Apr 17.PMID: 22510424
- Goldstein DJ, Bello R, Shin JJ, Stevens G, Zolty R, Maybaum S, D'Alessandro D. Outcomes of cardiac transplantation in septuagenarians. J Heart Lung Transplant. 2012 Jul;31(7):679-85. doi: 10.1016/j.healun.2012.03.019. Epub 2012 May 2. PMID: 22554672
- Shore S, Aggarwal V, Zolty R. Carvedilol or sustained-release metoprolol for congestive heart failure: a comparative effectiveness analysis. J Card Fail. 2012 Dec;18(12):919-24. doi: 10.1016/j.cardfail.2012.10.016. PMID: 23207080
- Mazurek JA, Horne BD, Kelesidis I, Salamon JN, Zolty R. Relaxin levels in pulmonary hypertension: a comparison between pulmonary arterial hypertension and diastolic heart failure-induced pulmonary hypertension. J Heart Lung Transplant. 2013 Mar;32(3):371-4. doi: 10.1016/j.healun.2012.11.030. Epub 2012 Dec 28.PMID: 23273743
- McMurray JJ, Anand IS, Diaz R, Maggioni AP, O'Connor C, Pfeffer MA, Solomon SD, Tendera M, van Veldhuisen DJ, Albizem M, Cheng S, Scarlata D, Swedberg K, Young JB, RED-HF Committees Investigators. Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF). Eur J Heart Fail. 2013 Mar;15(3):334-41. doi: 10.1093/eurjhf/hfs204. Epub 2013 Jan 17.PMID: 23329651
- Swedberg K, Young JB, Anand IS, Cheng S, Desai AS, Diaz R, Maggioni AP, McMurray JJ, O'Connor C, Pfeffer MA, Solomon SD, Sun Y, Tendera M, van Veldhuisen DJ, RED-HF Committees, RED-HF Investigators. Treatment of anemia with darbepoetin alfa in systolic heart failure. N Engl J Med. 2013 Mar 28;368(13):1210-9. doi: 10.1056/NEJMoa1214865. Epub 2013 Mar 10. PMID: 23473338
- Gheorghiade M, Böhm M, Greene SJ, Fonarow GC, Lewis EF, Zannad F, Solomon SD, Baschiera F, Botha J, Hua TA, Gimpelewicz CR, Jaumont X, Lesogor A, Maggioni AP, ASTRONAUT Investigators and Coordinators. Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial. JAMA. 2013 Mar 20;309(11):1125-35. doi: 10.1001/jama.2013.1954. PMID: 23478743
- Kelesidis I, Mazurek JA, Saeed W, Chaudhari R, Velankar P, Zolty R. Effect of nesiritide in isolated right ventricular failure secondary to pulmonary hypertension. Congest Heart Fail. 2012 Jan-Feb;18(1):18-24. doi:10.1111/j.1751-7133.2011.00273.x. Epub 2011 Nov 27. PMID: 22277173
- Rabinovitz A, Raiszadeh F, Zolty R. Association of hyponatremia and outcomes in pulmonary hypertension. J Card Fail. 2013 Aug;19(8):550-6. doi: 10.1016/j.cardfail.2013.05.014. PMID: 23910584
- Kelesidis I, Hourani P, Varughese C, Zolty R. Effect of race on left ventricular ejection fraction decline after initial improvement with beta blockers in patients with non-ischemic cardiomyopathy: a retrospective analysis. Drugs R D. 2013 Sep;13(3):183-90. doi: 10.1007/s40268-013-0021-9. PMID: 23949921
- Kelesidis I, Varughese CJ, Hourani P, Zolty R. Effects of ß-adrenergic blockade on left ventricular remodeling among Hispanics and African Americans with chronic heart failure. Clin Cardiol. 2013 Oct;36(10):595-602. doi: 10.1002/clc.22164. Epub 2013 Jul 24. PMID: 23893765
- Maggioni AP, Greene SJ, Fonarow GC, BÃÂhm M, Zannad F, Solomon SD, Lewis EF, Baschiera F, Hua TA, Gimpelewicz CR, Lesogor A, Gheorghiade M, ASTRONAUT Investigators and Coordinators. Effect of aliskiren on post-discharge outcomes among diabetic and non-diabetic patients hospitalized for heart failure: insights from the ASTRONAUT trial. Eur Heart J. 2013 Oct;34(40):3117-27. doi10.1093/eurheartj/eht342. Epub 2013 Sep 2. PMID: 23999456
- Toma M, Ezekowitz JA, Bakal JA, O'Connor CM, Hernandez AF, Sardar MR, Zolty R, Massie BM, Swedberg K, Armstrong PW, Starling RC. The relationship between left ventricular ejection fraction and mortality in patients with acute heart failure: insights from the ASCEND-HF Trial. Eur J Heart Fail. 2014 Mar;16(3):334-41. doi: 10.1002/ejhf.19. Epub 2013 Dec 14. PMID: 24464687
- Kadavath S, Zapantis E, Zolty R, Efthimiou P. A novel therapeutic approach in pulmonary arterial hypertension as a complication of adult-onset Still's disease: targeting IL-6. Int J Rheum Dis. 2014 Mar;17(3):336-40. doi: 10.1111/1756-185X.12324. PMID: 24581387
- Mojadidi MK, Winoker JS, Roberts SC, Msaouel P, Gevorgyan R, Zolty R. Two-dimensional echocardiography using second harmonic imaging for the diagnosis of intracardiac right-to-left shunt: a meta-analysis of prospective studies. Int J Cardiovasc Imaging. 2014 Jun;30(5):911-23. doi: 10.1007/s10554-014-0426-8. Epub 2014 Apr 17. PMID: 24740212
- Salamon JN, Kelesidis I, Msaouel P, Mazurek JA, Mannem S, Adzic A, Zolty R. Outcomes in World Health Organization group II pulmonary hypertension: mortality and readmission trends with systolic and preserved ejection fraction-induced pulmonary hypertension. J Card Fail. 2014 Jul;20(7):467-75. doi: 10.1016/j.cardfail.2014.05.003. Epub 2014 May 23. PMID: 24858070
- Halperin JL, Hankey GJ, Wojdyla DM, Piccini JP, Lokhnygina Y, Patel MR, Breithardt G, Singer DE, Becker RC, Hacke W, Paolini JF, Nessel CC, Mahaffey KW, Califf RM, Fox KA, ROCKET AF Steering Committee and Investigators. Efficacy and safety of rivaroxaban compared with warfarin among elderly patients with nonvalvular atrial fibrillation in the Rivaroxaban Once Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF). Circulation. 2014 Jul 8;130(2):138-46. doi: 10.1161/CIRCULATIONAHA.113.005008. Epub 2014 Jun 3. PMID: 24895454
- Holzhauser L, Zolty R. Endothelin receptor polymorphisms in the cardiovascular system: potential implications for therapy and screening. Heart Fail Rev. 2014 Nov;19(6):743-58. doi: 10.1007/s10741-014-9426-y. PMID: 24570333
- Mojadidi MK, Goodman-Meza D, Eshtehardi P, Pamerla M, Msaouel P, Roberts SC, Winoker JS, Jadeja NM, Zolty R. Thrombocytopenia is an independent predictor of mortality in pulmonary hypertension. Heart Lung. 2014 Nov-Dec;43(6):569-73. doi: 10.1016/j.hrtlng.2014.07.006. Epub 2014 Aug 29. PMID: 25169667
- Kao D, Lowes B, Gilbert E, Minobe W, Epperson LE, Meyer L, Ferguson D, Volkman K, Zolty R, Borg D, Quaife R, Bristow M. Therapeutic Molecular Phenotype of ß-blocker Associated Reverse-Remodeling in Nonischemic Dilated Cardiomyopathy. Circ Cardiovasc Genet. 2015 Apr;8(2):270-83. doi: 10.1161/CIRCGENETICS.114.000767. Epub 2015 Jan 30. PMID: 25637602
- Selim AM, Mazurek JA, Iqbal M, Wang D, Negassa A, Zolty R. Mortality and readmission rates in patients hospitalized for acute decompensated heart failure: a comparison between cardiology and general-medicine service outcomes in an underserved population. Clin Cardiol. 2015 Mar;38(3):131-8. doi: 10.1002/clc.22372. Epub 2015 Feb 18. PMID: 25694226
- Saeed O, Jermyn R, Kargoli F, Madan S, Mannem S, Gunda S, Nucci C, Farooqui S, Hassan S, Mclarty A, Bloom M, Zolty R, Shin J, D'Alessandro D, Goldstein DJ, Patel SR. Blood pressure and adverse events during continuous flow left ventricular assist device support. Circ Heart Fail. 2015 May;8(3):551-6. doi: 10.1161/CIRCHEARTFAILURE.114.002000. Epub 2015 Apr 13.PMID: 25870369
- Eshtehardi P, Pamerla M, Mojadidi MK, Goodman-Meza D, Hovnanians N, Gupta A, Lupercio F, Mazurek JA, Zolty R. Addition of angiotensin-converting enzyme inhibitors to beta-blockers has a distinct effect on hispanics compared with african americans and whites with heart failure and reduced ejection fraction: a propensity score-matching study. J Card Fail. 2015 Jun;21(6):448-56. doi: 10.1016/j.cardfail.2015.03.010. Epub 2015 Mar 21. PMID: 25805065
- Pokorney SD, Piccini JP, Stevens SR, et al. ROCKET AF Steering Committee & Investigators. Cause of Death and Predictors of All-Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF.; J Am Heart Assoc. 2016 Mar 8;5(3):e002197. doi: 10.1161/JAHA.115.002197.PMID: 26955859
- Raichlin E, Baibhav B, Lowes BD, Zolty R, Lyden ER, Vongooru HR, Siddique A, Moulton MJ, Um JY. Outcomes in Patients with Severe Pre-existing Renal Dysfunction after Continuous Flow Left Ventricular Assist Device Implantation. ASAIO J. 2016 May-Jun;62(3):261-7. doi: 10.1097/MAT.0000000000000330. PMID: 26735558
- Mojadidi MK, Galeas JN, Goodman-Meza D, Eshtehardi P, Msaouel P, Kelesidis I, Zaman MO, Winoker JS, Roberts SC, Christia P, Zolty R. Thrombocytopaenia as a Prognostic Indicator in Heart Failure with Reduced Ejection Fraction. Heart Lung Circ. 2016 Jun;25(6):568-75. doi: 10.1016/j.hlc.2015.11.010. Epub 2016 Jan 18.PMID: 26868831
- Lenihan DJ, Anderson SA, Lenneman CG, Brittain E, Muldowney JAS 3rd, Mendes L, Zhao PZ, Iaci J, Frohwein S, Zolty R, Eisen A, Sawyer DB, Caggiano AO A Phase I, Single Ascending Dose Study of Cimaglermin Alfa (Neuregulin 1ß3) in Patients With Systolic Dysfunction and Heart Failure. JACC Basic Transl Sci. 2016 Dec 26;1(7):576-586. doi: 10.1016/j.jacbts.2016.09.005. eCollection 2016 Dec. PMID: 30167542
- Dhar K, Moulton AM, Rome E, Qiu F, Kittrell J, Raichlin E, Zolty R, Um JY, Moulton MJ, Basma H, Anderson DR, Eudy JD, Lowes BD. Targeted myocardial gene expression in failing hearts by RNA sequencing. J Transl Med. 2016 Nov 25;14(1):327. doi: 10.1186/s12967-016-1083-6. PMID: 27884156
- Parry TJ, Ganguly A, Troy EL, Luis Guerrero J, Iaci JF, Srinivas M, Vecchione AM, Button DC, Hackett CS, Zolty R, Sawyer DB, Caggiano AO. Effects of neuregulin GGF2 (cimaglermin alfa) dose and treatment frequency on left ventricular function in rats following myocardial infarction. Eur J Pharmacol. 2017 Feb 5;796:76-89. doi: 10.1016/j.ejphar.2016.12.024. Epub 2016 Dec 16. PMID: 27993643
- Peled Y, Varnado S, Lowes BD, Zolty R, Lyden ER, Moulton MJ, Um JY, Raichlin E. Sinus Tachycardia Is Associated with Impaired Exercise Tolerance following Heart Transplantation. Clin Transplant. 2017 May;31(5). doi: 10.1111/ctr.12946. Epub 2017 Apr 9. PMID: 28251691
- Selim A, Zolty R, Chatzizisis YS, The Evolution of Heart Failure with Reduced Ejection Fraction Pharmacotherapy: What do we have and where are we going? Pharmacol Ther. 2017 Oct;178:67-82. doi: 10.1016/j.pharmthera.2017.03.011. Epub 2017 Mar 21. PMID: 28336474
- Zolty R. Pulmonary Hypertension in Left Ventricular Dysfunction: Still Numerous Unanswered Questions. J Card Fail. 2017 Mar;23(3):221-223. doi: 10.1016/j.cardfail.2017.01.008. Epub 2017 Jan 23. PMID: 28126498
- Mehta RH, Leimberger JD, van Diepen S, et al. LEVO-CTS Investigators. Levosimendan in Patients with Left Ventricular Dysfunction Undergoing Cardiac Surgery.N Engl J Med. 2017 May 25;376(21):2032-2042. doi: 10.1056/NEJMoa1616218. Epub 2017 Mar 19.PMID: 28316276
- Selim AM, Sarswat N, Kelesidis I, Iqbal M, Chandra R, Zolty R. Plasma Serotonin in Heart Failure: Possible Marker and Potential Treatment Target. Heart Lung Circ. 2017 May;26(5):442-449. doi: 10.1016/j.hlc.2016.08.003. Epub 2016 Sep 17. PMID: 27746058
- Varnado S, Peled-Potashnik Y, Huntsberry A, Lowes BD, Zolty R, Burdorf A, Lyden ER, Moulton MJ, UmJY, Raichlin E. Effect of Diltiazem on Exercise Capacity after Heart Transplantation. Clin Transplant. 2017 Aug;31(8). doi: 10.1111/ctr.12997. Epub 2017 Jul 21. PMID: 28477381
- Holzhauser L, Hovnanians N, Eshtehardi P, Mojadidi MK, Deng Y, Goodman-Meza D, Msaouel P, Ko YA, Zolty R. Statin therapy improves survival in patients with severe pulmonary hypertension: a propensity score matching study.Heart Vessels. 2017 Aug;32(8):969-976. doi: 10.1007/s00380-017-0957-8. Epub 2017 Mar 16. PMID: 28303379
- Selim A, Zolty R, Chatzizisis YS. New heart failure pharmacotherapy in clinical trials: a hope in progress. Expert Rev Cardiovasc Ther. 2017 Sep;15(9):649-651. doi: 10.1080/14779072.2017.1358614. Epub 2017 Jul 28. PMID: 28724329
- Lundgren S, Poon CYM, Selim A, Lowes BD, Zolty R, Burdorf A, Potashnik-Peled Y, Moulton MJ, Um JY, Raichlin E. Depression and Anxiety in patients undergoing left ventricular assist device implantation. Int J Artif Organs, 2017 Nov 1:0. Doi: 10.5301/ljao.5000650. PMID: 29099540
- Mazurek JA, Horne BD, Saeed W, Sardar MR, Zolty R. Galectin-3 Levels Are Elevated and Predictive of Mortality in Pulmonary Hypertension. Heart Lung Circ. 2017 Nov;26(11):1208-1215. doi: 10.1016/j.hlc.2016.12.012. Epub 2017 Feb 8. PMID: 28242288
- Selim AM, Wadhwani L, Burdorf A, Raichlin E, Lowes BD, Zolty R. Left Ventricular Assist Devices In Pulmonary Hypertension Group 2 With Significantly Elevated Pulmonary Vascular Resistance: A Bridge To Cure. Heart Lung Circ. 2019 Jun;28(6):946-952. doi: 10.1016/j.hlc.2018.04.299. Epub 2018 May 18.PMID: 29895486
- Lundgren S, Lowes BD, Zolty R, Burdorf A, Raichlin E, Um JY, Poon C. Do Psychosocial Factors Have Any Impact on Outcomes After Left Ventricular Assist Device Implantation?ASAIO J. 2018 Jul/Aug;64(4):e43-e47. doi: 10.1097/MAT.0000000000000736. PMID: 29210773
- Patel AD, Lowes B, Chamsi-Pasha MA, Radio SJ, Hyden M, Zolty R. Sirolimus for Recurrent Giant Cell Myocarditis after Heart Transplantation, a Unique Therapeutic Strategy. Am J Ther. 2019 Sep/Oct;26(5):600-603. doi10.1097/MJT.0000000000000796. PMID: 29889677
- Lundgren S, Lyden E, Stoller D, Hyden M, Burdorf A, Zolty R, Um J, Lowes B. Electrocardiographic characteristics, antiarrhythmic utilization, and outcomes in patients with left ventricular assist devices. The VAD Journal, 4. doi:https://doi.org/10.13023/vad. 2018.08
- Newman J, Liebo M, Lowes BD, Ilias Basha H, Peled Y, Cendrowski E, Zolty R, Douglas D, Um JY, McGee E Jr., Heroux A, Raichlin E, The Effect of Donor Alcohol Abuse on Outcomes Following Heart Transplantation. Clin Transplant. 2019 Feb;33(2):e13461. doi: 10.1111/ctr.13461. Epub 2019 Jan 24.PMID: 30536743
- Liebo M, Newman J Joshi A, Lowes BD, Peled-Potashnik Y, Basha HI, Zolty R, Um JY, McGee E Jr., Heroux A, Raichlin E. Elevated Heart Rate Following Heart Transplantation is associated with Increased Graft Vasculopathy and Mortality. J Card Fail. 2019 Apr;25(4):249-256. doi: 10.1016/j.cardfail.2019.01.009. Epub 2019 Jan 24. PMID: 30685400
- Velazquez EJ, Morrow DA, DeVore AD, Duffy CI, Ambrosy AP, McCague K, Rocha R, Braunwald E; PIONEER-HF Investigators. Angiotensin-Neprilysin Inhibition in Acute Decompensated Heart Failure.N Engl J Med. 2019 Feb 7;380(6):539-548. doi: 10.1056/NEJMoa1812851. Epub 2018 Nov 11.PMID: 30415601
- Metra M, Teerlink JR, Cotter G, et al. RELAX-AHF-2 Committees Investigators. Effects of Serelaxin in Patients with Acute Heart Failure.N Engl J Med. 2019 Aug 22;381(8):716-726. doi: 10.1056/NEJMoa1801291.PMID: 31433919
- Urban M, Um J, Moulton M, Stoller D, Zolty R, Lowes B, Macdonald C, McCain N, Siddique A. Recurrent pump thrombosis is common after axial continuous-flow left ventricular assist device exchange. Int J Artif Organs. 2020 Feb;43(2):109-118. doi: 10.1177/0391398819876293. Epub 2019 Sep 18. PMID: 31530254
- Albulushi A, Zolty R, Lowes B, Duhacheck-Stapleman AL, Sandler T, Sullivan JN, Stoller D. Perioperative Management of Pheochromocytoma Resection in a Patient with a Continuous Flow left Ventricular Assist Device.J Saudi Heart Assoc. 2020 Jul 15;32(2):233-235. doi: 10.37616/2212-5043.1026. eCollection 2020. PMID: 33154922
- Albulushi A, Goldsweig AM, Stoller D, Delaney JW, Um J, Lowes B, Zolty R. Percutaneous Deactivation of Left Ventricular Assist Devices. Semin Thorac Cardiovasc Surg. 2020 Autumn;32(3):467-472. doi: 10.1053/j.semtcvs.2020.01.012. Epub 2020 Feb 10. PMID: 32057968
- Zolty R, Challenges in pulmonary hypertension associated with left heart disease. Expert Rev Cardiovasc Ther. 2019 Jun;17(6):461-472. doi: 10.1080/14779072.2019.1615885. Epub 2019 Jun 4. PMID: 31107116
- Lundgren SW, Florescu DF, Zolty R. Reactivation of Cytomegalovirus Following Left Ventricular Assist Device Implantation: A Case-Control Study. ASAIO J. 2020 Jul 23. doi: 10.1097/MAT.0000000000001236. PMID: 32740125
- Yu MD, Liebo MJ, Lundgren S, Salim AM, Joyce C, Zolty R, Moulton MJ, Um JY, Lowes BD, Raichlin E. Impaired Exercise Tolerance Early After Heart Transplantation Is Associated With Development of Cardiac Allograft Vasculopathy. Transplantation. 2020 Oct;104(10):2196-2203. doi: 10.1097/TP.0000000000003110. PMID: 31929429
- Zolty R. Pulmonary arterial hypertension specific therapy: The old and the new. Pharmacol Ther. 2020 Oct;214:107576. doi: 10.1016/j.pharmthera.2020.107576. Epub 2020 May 15. PMID: 32417272
- Sundarevel S, Asaweer M, Stoller D, Chatzizisis I, Zolty R. Methylene Blue to the Rescue in Accidental Trepostinil Overdose. Cardiol Cardiovasc Med 2020; 4(4): 443-449. DOI: 10.26502/fccm.92920142
- Gajanan G, Brilakis ES, Siller-Matula JM, Zolty RL, Velagapudi P. The Intra-Aortic Balloon Pump. J Vis Exp. 2021 Feb 5;(168). doi: 10.3791/62132. PMID: 33616109
- Liebo M, Newman J, Yu M, Hussain Z, Malik S, Lowes B, Joyce C, Zolty R, Basha HI, Heroux A, McGee E Jr, Um JY, Raichlin E. Preoperative Right Heart Dysfunction and Gastrointestinal Bleeding in Patients with Left Ventricular Assist Devices.ASAIO J. 2021 Mar 1;67(3):324-331. doi: 10.1097/MAT.0000000000001224. PMID: 33627608
- 1986: Tissot Award. Best Student Award, University of Geneva, Geneva, Switzerland.
- 2009: Teaching Award, Albert Einstein College of Medicine of Yeshiva University/Montefiore Medical Center, Bronx, New York, United States.
- 2011: Teaching Award, Albert Einstein College of Medicine of Yeshiva University/Montefiore Medical Center, Bronx, New York, United States.